3-7740807-A-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2

The NM_000844.4(GRM7):​c.*401A>T variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.0077 in 162,640 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0076 ( 9 hom., cov: 32)
Exomes 𝑓: 0.0095 ( 1 hom. )

Consequence

GRM7
NM_000844.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 5.01

Publications

5 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00757 (1151/152052) while in subpopulation SAS AF = 0.0256 (123/4796). AF 95% confidence interval is 0.022. There are 9 homozygotes in GnomAd4. There are 596 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRM7NM_000844.4 linkc.*401A>T 3_prime_UTR_variant Exon 10 of 10 ENST00000357716.9 NP_000835.1 Q14831-1B2R693Q59G95
GRM7NM_181874.3 linkc.*472A>T 3_prime_UTR_variant Exon 11 of 11 NP_870989.1 Q14831-2B2R693B9EGG9
GRM7XM_017006272.2 linkc.*472A>T 3_prime_UTR_variant Exon 11 of 11 XP_016861761.1
GRM7XM_017006273.2 linkc.*401A>T 3_prime_UTR_variant Exon 10 of 10 XP_016861762.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRM7ENST00000357716.9 linkc.*401A>T 3_prime_UTR_variant Exon 10 of 10 1 NM_000844.4 ENSP00000350348.4 Q14831-1

Frequencies

GnomAD3 genomes
AF:
0.00758
AC:
1152
AN:
151934
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00189
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.00427
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0258
Gnomad FIN
AF:
0.0171
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00969
Gnomad OTH
AF:
0.00960
GnomAD4 exome
AF:
0.00954
AC:
101
AN:
10588
Hom.:
1
Cov.:
0
AF XY:
0.0102
AC XY:
56
AN XY:
5472
show subpopulations
African (AFR)
AF:
0.00204
AC:
1
AN:
490
American (AMR)
AF:
0.00
AC:
0
AN:
284
Ashkenazi Jewish (ASJ)
AF:
0.00448
AC:
2
AN:
446
East Asian (EAS)
AF:
0.00
AC:
0
AN:
616
South Asian (SAS)
AF:
0.0795
AC:
7
AN:
88
European-Finnish (FIN)
AF:
0.0220
AC:
19
AN:
862
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
58
European-Non Finnish (NFE)
AF:
0.00875
AC:
61
AN:
6972
Other (OTH)
AF:
0.0142
AC:
11
AN:
772
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00757
AC:
1151
AN:
152052
Hom.:
9
Cov.:
32
AF XY:
0.00802
AC XY:
596
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.00188
AC:
78
AN:
41480
American (AMR)
AF:
0.00426
AC:
65
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.0256
AC:
123
AN:
4796
European-Finnish (FIN)
AF:
0.0171
AC:
181
AN:
10570
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00969
AC:
659
AN:
68008
Other (OTH)
AF:
0.00950
AC:
20
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00102
Hom.:
0
Bravo
AF:
0.00581
Asia WGS
AF:
0.00693
AC:
24
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
15
DANN
Benign
0.83
PhyloP100
5.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56173829; hg19: chr3-7782494; API